Effects of different TLR Agonists on in vivo cDC1 and in vivo cDC2 Activation

Authors

Katherine E. Nowak, The University of Texas MD Anderson Cancer Center
Bailey N. Harmon, The University of Texas MD Anderson Cancer CenterFollow
Allison M. Dyevoich PhD, The University of Texas MD Anderson Cancer Center
Stephanie S. Watowich PhD, The University of Texas MD Anderson Cancer Center

Files

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Keywords

cDC1; cDC2; dendritic cell activation; costimulatory molecules; TLR agonists

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Program Affiliation

CPRIT-CURE Summer Undergraduate Program

Recommended Citation

Nowak, Katherine E.; Harmon, Bailey N.; Dyevoich, Allison M. PhD; and Watowich, Stephanie S. PhD, "Effects of different TLR Agonists on in vivo cDC1 and in vivo cDC2 Activation" (2021). Summer Experience 2021. 167.
https://openworks.mdanderson.org/sumexp21/167